Preparation of chitosan/retinoic acid @ nanocapsules/TiO<sub>2</sub> self-cleaning one-dimensional photonic crystals and the study of the visual detection of acute promyelocytic leukemia-Reference-Cited by-同舟云学术

Preparation of chitosan/retinoic acid @ nanocapsules/TiO₂ self-cleaning one-dimensional photonic crystals and the study of the visual detection of acute promyelocytic leukemia

Published:2023 Issue:27 Volume:13 Page:18363-18370
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Li Shuai¹²,Wang Zhiqiang²,Chen Yanying³,Zou Qing⁴,Zou Qianqian⁵,Wang Long²,Zhu Yanxi²^ORCID,Wang Lijuan²⁴⁶⁷⁸

Affiliation:

1. Qingdao University, Qingdao, Shandong Province, China

2. Central Laboratory, Linyi People's Hospital, Linyi, Shandong Province, China

3. Laboratory of Hematology, Linyi People's Hospital, Linyi, Shandong Province, China

4. Department of Hematology, Linyi People's Hospital, Linyi, Shandong Province, China

5. Laboratory Department, Traditional, Chinese Medicine Hospital of Linyi, Linyi, Shandong Province, China

6. Key Laboratory of Neurophysiology, Health Commission of Shandong Province, Linyi, Shandong Province, China

7. Key Laboratory for Translational Oncolgoy, Xuzhou Medical University, Linyi, Shandong Province, China

8. Linyi Key Laboratory of Tumor Biology, Linyi, Shandong Province, China

Abstract

The visualization sensor cannot only detect acute promyelocytic leukemia conveniently, quickly and accurately, but also kill bacteria and decompose organic residues in blood samples under the influence of sunlight.

Funder

Medical and Health Science and Technology Development Project of Shandong Province

Xuzhou Medical University

Natural Science Foundation of Shandong Province

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/RA/D3RA02224B

Reference47 articles.

1. Acute promyelocytic leukemia and variant fusion proteins: PLZF-RARα fusion protein at a glance

2. Acute promyelocytic leukemia current treatment algorithms

3. Decreased tissue factor and tissue-plasminogen activator antigen in relapsed acute promyelocytic leukemia

4. Advances in the management of coagulopathy in acute promyelocytic leukemia